Published ahead of print on August 20, 2007, doi:10.1165/rcmb.2007-0197OC
Am. J. Respir. Cell Mol. Biol., Volume 38, Number 2, February 2008, 176-184
A more recent version of this article appeared on February 1, 2008
Submitted on June 4, 2007
Revised on August 15, 2007
CHOP Transcription Factor Mediates IL-8 Signaling in Cystic Fibrosis Bronchial Epithelial Cells
Neeraj Vij1, Martha O Amoako1, Steven Mazur1, and Pamela L Zeitlin1*
1 Division of Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
* To whom correspondence should be addressed. E-mail: pzeitlin{at}jhmi.edu.
Interleukin (IL)-8 is a potent neutrophil chemo-attractant that drives the inflammatory response in cystic fibrosis. Traditional approaches to the pathophysiology of this inflammation have focused on targeting NF B-dependent signaling and therapy with glucocorticoids. We test the hypothesis that an alternative pathway, independent of NF B, operates through prostaglandin E2 (PGE-2) receptor EP-2 and stimulates IL-8 chemokine secretion. Using CF bronchial epithelial cells (IB3-1) in vitro, exogenous PGE-2 induces IL-8 release in a dose dependent manner. These events are associated with elevation in the EP-2 receptors. Inhibition of cyclo-oxygenase (Cox)-2 with NS-398 was associated with reductions in Cox-2 (2-fold) and IL-6 (1.3 fold) mRNA transcripts, and in IL-8 and PGE-2 chemokine secretion. The inhibition of Cox-2 signaling led to down-regulation of the downstream CHOP (C/EBP homologous protein) transcription factor resulting in a decrease in IL-8 activation. We confirmed the regulation of IL-8 promoter by CHOP in CF cells using the IL-8 reporter assay. We conclude that PGE-2 stimulates IL-8 production through the CHOP transcription factor in CF cells.
This article has been cited by other articles:

|
 |

|
 |
 
M. Cucinotta, M. Visalli, M. Aguennouz, A. Valenti, S. Loddo, L. Altucci, and D. Teti
Regulation of Interleukin-8 Gene at a Distinct Site of Its Promoter by CCAAT Enhancer-binding Protein Homologous Protein in Prostaglandin E2-treated Human T Cells
J. Biol. Chem.,
October 31, 2008;
283(44):
29760 - 29769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Roque, E. Boncoeur, V. Saint-Criq, E. Bonvin, A. Clement, O. Tabary, and J. Jacquot
Proinflammatory Effect of Sodium 4-Phenylbutyrate in {Delta}F508-Cystic Fibrosis Transmembrane Conductance Regulator Lung Epithelial Cells: Involvement of Extracellular Signal-Regulated Protein Kinase 1/2 and c-Jun-NH2-Terminal Kinase Signaling
J. Pharmacol. Exp. Ther.,
September 1, 2008;
326(3):
949 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Blohmke, R. E. Victor, A. F. Hirschfeld, I. M. Elias, D. G. Hancock, C. R. Lane, A. G. F. Davidson, P. G. Wilcox, K. D. Smith, J. Overhage, et al.
Innate Immunity Mediated by TLR5 as a Novel Antiinflammatory Target for Cystic Fibrosis Lung Disease
J. Immunol.,
June 1, 2008;
180(11):
7764 - 7773.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society.
|
|
|